Neuralink says it received US FDA approval to launch its first-in-human clinical study of brain implants (Akriti Sharma/Reuters)

Akriti Sharma / Reuters:

Neuralink says it received US FDA approval to launch its first-in-human clinical study of brain implants  —  Elon Musk’s brain-implant company Neuralink on Thursday said it had received U.S. Food and Drug Administration’s (FDA) approval to launch first-in-human clinical study.